重大事件
外國發行人報告
6-K
2026-06-30
Radiopharm Theranostics 約3,722萬份未上市期權因條件未獲滿足失效
AI 繁中摘要
美國 SEC EDGAR 6-K 申報摘要：Radiopharm Theranostics Limited（ASX：RAD）
申報類型：6-K（外國私人發行人根據1934年證券交易法提交報告）
事件重點：公司向ASX提交證券終止通知（Appendix 3H），披露多批未上市期權因條件未獲滿足而失效，總共約3,722萬份期權已停止流通。
關鍵數字（失效期權明細）：
- 8,540,000 份期權（到期日不同，行使價各異），終止日期：2026年5月15日。
- 17,305,743 份期權，終止日期：2026年1月30日。
- 10,666,666 份期權，終止日期：2025年11月20日。
- 712,301 份期權（行使價0.17澳元，到期日2027年7月1日），終止日期：2025年11月20日。
全部因條件失效而終止，公司無需支付任何對價。
終止後已發行證券概況（截至申報日期）：
- 上市普通股（RAD）：3,544,216,160 股。
- 上市期權（RADO：2026年11月30日到期）：79,352,040 份。
- 上市期權（RADOA：2026年8月24日到期）：818,890,534 份。
- 上市期權（RADOB：2027年10月31日到期）：1,179,266,658 份。
- 未上市期權：包括RADAN（各種到期日/行使價）384,512,859 份、RADAJ（2027年7月1日到期，行使價0.17澳元）12,425,675 份等。
管理層展望：文件中未提供管理層展望或業績評論，純屬證券結構變動通知。
對投資者的潛在影響 🧐：本次期權失效減少潛在股權稀釋，但涉及數量相對已發行股本不算極大。投資者需留意未上市期權仍大量存在（如RADAN系列逾3.8億份），未來若條件滿足仍可能轉換為普通股。整體資本結構維持穩定，短期內無現金支出。建議關注公司後續業務進展及任何股本集資活動。
展開英文正文
EX-99.1 2 ea029645901ex99-1.htm NOTIFICATION OF CESSATION OF SECURITIES - RAD Exhibit 99.1 Appendix 3H - Notification of cessation of securities Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday June 30, 2026 Details of +securities that have ceased ASX +security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation RADAN OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 8,540,000 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 15/05/2026 RADAN OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 17,305,743 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 30/01/2026 RADAN OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 10,666,666 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 20/11/2025 RADAN OPTION EXPIRING 01-JUL-2027 EX $0.17 712,301 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 20/11/2025 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities1 / 5 Appendix 3H - Notification of cessation of securities Part 1 - Announcement Details 1.1Name of +Entity RADIOPHARM THERANOSTICS LIMITED We (the entity named above) provide the following information about our issued capital. 1.2Registered Number Type Registration Number ACN 647877889 1.3ASX issuer code RAD 1.4The announcement is New announcement 1.5Date of this announcement 30/6/2026 Appendix 3H - Notification of cessation of securities2 / 5 Appendix 3H - Notification of cessation of securities Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Unquoted +equity securities that have ceased Number of securities that have ceased 8,540,000 Reason for cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied Date of cessation Is the entity paying any consideration for the cessation? 15/5/2026 No Any other information the entity wishes to notify to ASX about the cessation? ASX +Security Code and Description RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Unquoted +equity securities that have ceased Number of securities that have ceased 17,305,743 Reason for cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied Date of cessation Is the entity paying any consideration for the cessation? 30/1/2026 No Any other information the entity wishes to notify to ASX about the cessation? Appendix 3H - Notification of cessation of securities3 / 5 Appendix 3H - Notification of cessation of securities ASX +Security Code and Description RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Unquoted +equity securities that have ceased Number of securities that have ceased 10,666,666 Reason for cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied Date of cessation Is the entity paying any consideration for the cessation? 20/11/2025 No Any other information the entity wishes to notify to ASX about the cessation? ASX +Security Code and Description RADAJ : OPTION EXPIRING 01-JUL-2027 EX $0.17 Unquoted +equity securities that have ceased Number of securities that have ceased 712,301 Reason for cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied Date of cessation Is the entity paying any consideration for the cessation? 20/11/2025 No Any other information the entity wishes to notify to ASX about the cessation? Appendix 3H - Notification of cessation of securities4 / 5 Appendix 3H - Notification of cessation of securities Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue RADO : OPTION EXPIRING 30-NOV-2026 79,352,040 RAD : ORDINARY FULLY PAID 3,544,216,160 RADOA : OPTION EXPIRING 24-AUG-2026 818,890,534 RADOB : OPTION EXPIRING 31-OCT-2027 1,179,266,658 3.2Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue RADAK : OPTION EXPIRING 01-JUN-2027 EX $0.60 1,666,500 RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 384,512,859 RADAJ : OPTION EXPIRING 01-JUL-2027 EX $0.17 12,425,675 RADAF : OPTION EXPIRING 25-NOV-2026 RESTRICTED 8,666,678 RADAG : OPTION EXPIRING 25-NOV-2026 EX $0.60 5,066,672 RADAI : OPTION EXPIRING 27-MAY-2027 EX $0.60 740,000 RADAP : OPTION EXPIRING 24-APR-2028 EX $0.09 8,955,224 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form. Appendix 3H - Notification of cessation of securities5 / 5